Literature DB >> 28749894

Comparison of Outcomes Between Combined Transepithelial Photorefractive Keratectomy With and Without Accelerated Corneal Collagen Cross-Linking: A 1-Year Study.

Hun Lee1, David Sung Yong Kang, Byoung Jin Ha, Jin Young Choi, Eung Kweon Kim, Kyoung Yul Seo, Tae-Im Kim.   

Abstract

PURPOSE: To investigate the effects of combined transepithelial photorefractive keratectomy (tPRK) and accelerated corneal collagen cross-linking (CXL) on visual acuity and refractive outcomes.
METHODS: The medical records of 89 eyes (89 patients) undergoing combined tPRK and CXL (tPRK-CXL group) or tPRK alone (tPRK group) were retrospectively analyzed. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity, and manifest refraction spherical equivalent (MRSE) were evaluated preoperatively and 2 weeks, 1, 3, 6, and 12 months after surgery.
RESULTS: At 2 weeks after surgery, the tPRK-CXL group had better UDVA than the tPRK group (0.97 ± 0.22 vs. 0.85 ± 0.22, P = 0.015). At 2 weeks and 1 month after surgery, the tPRK-CXL group had a significantly lower spherical error than the tPRK group (0.24 vs. 0.63 D, P = 0.017, for 2 weeks and 0.43 vs. 0.57 D, P = 0.019, for 1 month). At 12 months after surgery, the tPRK-CXL group had a lower spherical error and MRSE than the tPRK group (0.30 vs. 0.44 D, P < 0.001, for the spherical error and 0.17 vs. 0.31 D, P < 0.001, for the MRSE). Both groups had comparable predictability, efficacy, and safety indices at 12 months after surgery.
CONCLUSIONS: Combined tPRK and accelerated CXL demonstrated comparable predictability, efficacy, and safety compared with tPRK alone. Combined tPRK and CXL provides better UDVA in the early postoperative period and better refractive outcomes at 12 months postoperatively in terms of spherical error and MRSE.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28749894     DOI: 10.1097/ICO.0000000000001308

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Visual rehabilitation in moderate keratoconus: combined corneal wavefront-guided transepithelial photorefractive keratectomy and high-fluence accelerated corneal collagen cross-linking after intracorneal ring segment implantation.

Authors:  Hun Lee; David Sung Yong Kang; Byoung Jin Ha; Jin Young Choi; Eung Kweon Kim; Kyoung Yul Seo; Tae-Im Kim
Journal:  BMC Ophthalmol       Date:  2017-12-29       Impact factor: 2.209

2.  Predictive Factors for Successful High Myopia Treatment Using High-Frequency Laser-In-Situ Keratomileusis.

Authors:  Widya Artini; Setyo B Riyanto; Johan A Hutauruk; Tjahjono D Gondhowiardjo; Aria Kekalih
Journal:  Open Ophthalmol J       Date:  2018-07-23

3.  Comparison of mechanical debridement and trans-epithelial myopic photorefractive keratectomy: A contralateral eye study.

Authors:  Siamak Zarei-Ghanavati; Javad Heravian Shandiz; Mojtaba Abrishami; Maliheh Karimpour
Journal:  J Curr Ophthalmol       Date:  2019-01-23

4.  Comparison of safety and efficiency of corneal topography-guided photorefractive keratectomy and combined with crosslinking in myopic correction: An 18-month follow-up.

Authors:  Li Li; Bo Zhang; Yijun Hu; Lu Xiong; Zheng Wang
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

Review 5.  Refractive surgery with simultaneous collagen cross-linking for borderline corneas - A review of different techniques, their protocols and clinical outcomes.

Authors:  Sheetal Brar; Megha Gautam; Smith Snehal Sute; Sri Ganesh
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

Review 6.  Preferred practice patterns for photorefractive keratectomy surgery.

Authors:  Rajesh Fogla; Gaurav Luthra; Aishwarya Chhabra; Krati Gupta; Ritika Dalal; Pooja Khamar
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

7.  Long-Term Follow-Up of Combined Photorefractive Keratectomy and Corneal Crosslinking in Keratoconus Suspects.

Authors:  George Kymionis; George Kontadakis; Michael Grentzelos; Myrsini Petrelli
Journal:  Clin Ophthalmol       Date:  2021-06-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.